Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Surefire Medical Raises $12.8 Million in Funding Led by Hong Kong Fund

publication date: Mar 3, 2017
Surefire Medical of Colorado, a company developing site-specific microcatheters for delivery of oncology drugs, raised $12.8 million in a D round led by ORI Healthcare Fund of Hong Kong. One of the uses of the new capital will be to start clinical trials and sales of Surefire's medical devices in China. Surefire claims that the expandable tip of its microcatheter increases pressure within the tumor and delivers more drug to the tumor than the competition, while decreasing delivery to surrounding tissue. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital